Effect of early tranexamic acid treatment on fatigue in patients with mild traumatic brain injury: data from the CRASH-3 clinical trial [version 3; peer review: 2 approved, 1 not approved]

Effect of early tranexamic acid treatment on fatigue in patients with mild traumatic brain injury: data from the CRASH-3 clinical trial [version 3; peer review: 2 approved, 1 not approved]

Background Each year world-wide about 65 million people sustain a mild traumatic brain injury (mTBI). Fatigue is a common and distressing symptom after mTBI. We examine the effect of tranexamic acid (TXA) on fatigue in patients with mTBI using data from the CRASH-3 trial. Methods The CRASH-3 trial r...

Full description

Saved in:
Bibliographic Details
Main Authors: Temitayo Shokunbi, Haleema Shakur-Still, Raoul Mansukhani, Antonio Belli, Rizwana Chaudhri, Sabariah Faizah Jamaluddin, Amy Brenner, Lauren Frimley, Rashid Jooma, Ian Roberts
Format: Article
Language:English
Published: Wellcome 2024-10-01
Series:Wellcome Open Research
Subjects:
Traumatic Brain Injury
Ttranexamic Acid
Fatigue
CRASH-3 trial
Randomised Controlled Trial
IntracranialHaemorrhage
eng
Online Access:https://wellcomeopenresearch.org/articles/6-346/v3
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://wellcomeopenresearch.org/articles/6-346/v3

Similar Items